☆ 4.7 Article

Quantity of IgG response to SARS-CoV-2 spike glycoprotein predicts pulmonary recovery from COVID-19

SCIENTIFIC REPORTS (2022)

Related references

Note: Only part of the references are listed.

Article Immunology

Incidence, Clinical Presentation, Relapses and Outcome of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection in Patients Treated With Anti-CD20 Monoclonal Antibodies

Jorge Calderon-Parra et al.

Summary: A retrospective cohort study of 422 patients under anti-CD20 treatment found that patients infected with COVID-19 within 6 months post-treatment had higher rates of hospital admission, mortality, and relapse, as well as longer infectivity of the virus.

CLINICAL INFECTIOUS DISEASES (2022)

Add to Collection

Article Immunology

Magnitude and Kinetics of Anti-Severe Acute Respiratory Syndrome Coronavirus 2 Antibody Responses and Their Relationship to Disease Severity

Kara L. Lynch et al.

Summary: Understanding the kinetics and magnitude of the host antibody response to SARS-CoV-2 is essential for understanding the pathogenesis of COVID-19 and identifying potential therapeutic targets. Research showed that IgM and IgG responses were significantly higher in patients with severe disease compared to those with mild disease, which may have implications for seroprevalence studies, therapeutics, and vaccine development strategies.

CLINICAL INFECTIOUS DISEASES (2021)

Add to Collection

Letter Infectious Diseases

Kinetics of SARS-CoV-2 specific antibodies (IgM, IgA, IgG) in non-hospitalized patients four months following infection

Dorothea Orth-Hoeller et al.

JOURNAL OF INFECTION (2021)

Add to Collection

Article Medicine, General & Internal

IL-6 and other biomarkers as predictors of severity in COVID-19

N. Broman et al.

Summary: IL-6 and CRP were found to be the strongest predictors of severity in hospitalized patients with COVID-19, showing significantly higher levels in patients eventually admitted to the ICU. No statistical differences were found in median levels of lymphocytes, D-dimer, or ferritin between the groups.

ANNALS OF MEDICINE (2021)

Add to Collection

Review Immunology

The COVID-19 pandemic and ANCA-associated vasculitis - reports from the EUVAS meeting and EUVAS education forum

Andreas Kronbichler et al.

Summary: The COVID-19 pandemic has impacted the management of patients with ANCA-associated vasculitis, leading to higher mortality rates and potential delays in diagnosis. The goal of treatment remains to suppress disease activity and reduce burden, but the use of rituximab may increase severity of COVID-19 hospital course and risk of re-infection.

AUTOIMMUNITY REVIEWS (2021)

Add to Collection

Article Medical Laboratory Technology

Evaluation of four commercial, fully automated SARS-CoV-2 antibody tests suggests a revision of the Siemens SARS-CoV-2 IgG assay

Christian Irsara et al.

Summary: This study evaluated the performance characteristics of four automated antibody assays for SARS-CoV-2, all of which showed very high diagnostic specificity. However, the sensitivities of some tests were slightly lower than manufacturer claims in samples collected at least 14 days after disease onset. The Siemens COV2G assay had distinctly lower sensitivity, necessitating a switch to the company's newly filed SARS-CoV-2 IgG assay for follow-up studies. Combination of multiple tests could be considered in clinical practice.

CLINICAL CHEMISTRY AND LABORATORY MEDICINE (2021)

Add to Collection

Article Respiratory System

Cardiopulmonary recovery after COVID-19: an observational prospective multicentre trial

Thomas Sonnweber et al.

Summary: A study found that some COVID-19 patients still experienced persistent symptoms and lung function impairment 100 days after the onset of the disease, but there was significant improvement in symptoms and cardiopulmonary status over time.

EUROPEAN RESPIRATORY JOURNAL (2021)

Add to Collection

Article Immunology

Role of Immunoglobulin M and A Antibodies in the Neutralization of Severe Acute Respiratory Syndrome Coronavirus 2

Jeromine Klingler et al.

Summary: The study found that spike- and RBD-specific IgM, IgG1, and IgA1 were produced by all or nearly all individuals in convalescent plasma, with these immunoglobulins playing critical roles in neutralizing the virus.

JOURNAL OF INFECTIOUS DISEASES (2021)

Add to Collection

Article Multidisciplinary Sciences

Evolution of antibody immunity to SARS-CoV-2

Christian Gaebler et al.

Summary: After infection with SARS-CoV-2, antibody levels against the spike protein decrease significantly, but the number of memory B cells remain unchanged, indicating an evolving humoral response at 6.2 months after infection.

NATURE (2021)

Add to Collection

Article Cell Biology

Enhanced SARS-CoV-2 neutralization by dimeric IgA

Zijun Wang et al.

Summary: The IgA response to SARS-CoV-2 was characterized in a cohort of 149 convalescent individuals after COVID-19 diagnosis. IgA responses in plasma generally correlated with IgG responses, and B cells producing IgM, IgG, and IgA were derived from common progenitor cells. Notably, IgA dimers were found to be 15 times more potent than IgA monomers against SARS-CoV-2, suggesting their potential value for protection and vaccine efficacy.

SCIENCE TRANSLATIONAL MEDICINE (2021)

Add to Collection

Article Cell Biology

IgA dominates the early neutralizing antibody response to SARS-CoV-2

Delphine Sterlin et al.

Summary: The study found that humoral immune responses to SARS-CoV-2 infection are dominated by IgA antibodies, with specific IgA plasmablasts rapidly expanding shortly after symptom onset and peaking in the third week of the disease. Virus-specific antibody responses include IgG, IgM, and IgA, with IgA playing a greater role in virus neutralization compared to IgG.

SCIENCE TRANSLATIONAL MEDICINE (2021)

Add to Collection

Article Medicine, Research & Experimental

An immune-based biomarker signature is associated with mortality in COVID-19 patients

Michael S. Abers et al.

Summary: Immune and inflammatory responses are important factors contributing to disease severity in COVID-19. This study identified specific immune-based biomarkers associated with mortality in COVID-19 patients, with some biomarkers consistently higher in those who died compared to those who recovered, suggesting their potential for early prediction of disease outcome.

JCI INSIGHT (2021)

Add to Collection

Article Multidisciplinary Sciences

Discrete SARS-CoV-2 antibody titers track with functional humoral stability

Yannic C. Bartsch et al.

Summary: The study reveals significant heterogeneity in antibody responses following SARS-CoV-2 infection, with limited decay of antibody titers over time. Observing neutralization, Fc-function, and SARS-CoV-2 specific T cell responses requires reaching a certain threshold of receptor-binding domain (RBD)-specific antibody titers, indicating a switch-like relationship between antibody titer and function.

NATURE COMMUNICATIONS (2021)

Add to Collection

Article Multidisciplinary Sciences

Role of IgG against N-protein of SARS-CoV2 in COVID19 clinical outcomes

Mayank Batra et al.

Summary: This study found that titers of IgG targeting N-protein of SARS-CoV2 at admission are related to the clinical course of the disease. Higher CCI and IL6 levels were independently associated with in-hospital mortality while maintaining a high S/Co ratio (>1.5) also led to MICU admission and longer hospital stays.

SCIENTIFIC REPORTS (2021)

Add to Collection

Article Hematology

Prolonged in-hospital stay and higher mortality after Covid-19 among patients with non-Hodgkin lymphoma treated with B-cell depleting immunotherapy

Remy Dulery et al.

Summary: Age >= 70 years, relapsed/refractory lymphoma, and recent administration of anti-CD20 therapy are risk factors for prolonged length of in-hospital stay and death for lymphoma patients hospitalized for Covid-19.

AMERICAN JOURNAL OF HEMATOLOGY (2021)

Add to Collection

Article Medical Laboratory Technology

Clinical validation of the Siemens quantitative SARS-CoV-2 spike IgG assay (sCOVG) reveals improved sensitivity and a good correlation with virus neutralization titers

Christian Irsara et al.

Summary: The clinical performance of the Siemens sCOVG assay was evaluated, with specificity of 99.4% and sensitivity of 90.5%. S1-RBD antibody levels showed good correlation with virus neutralization titers, serving as a surrogate for neutralizing capacity. Levels of S1-RBD IgG increase with age, with significantly higher levels observed in hospitalized COVID-19 patients compared to outpatients.

CLINICAL CHEMISTRY AND LABORATORY MEDICINE (2021)

Add to Collection

Article Immunology

Persistence of Antibody and Cellular Immune Responses in Coronavirus Disease 2019 Patients Over Nine Months After Infection

Lin Yao et al.

Summary: This study investigated the humoral and T and B cell responses in COVID-19 patients up to 343 days after infection. It found that most patients still had virus-specific immune memory responses approximately 1 year post-infection, which is promising for prevention from reinfection and vaccination strategies.

JOURNAL OF INFECTIOUS DISEASES (2021)

Add to Collection

Article Immunology

Marked Increase in Avidity of SARS-CoV-2 Antibodies 7-8 Months After Infection Is Not Diminished in Old Age

Daniel Pichler et al.

Summary: Research on IgG avidity maturation during SARS-CoV-2 infection showed an increase in avidity even in older individuals. High avidity was associated with residual neutralization capacity, especially in older age groups, highlighting the potential role of avidity assays as a cost-effective alternative for assessing immune system maturation and protection against further infections.

JOURNAL OF INFECTIOUS DISEASES (2021)

Add to Collection

Article Immunology

Naturally Acquired SARS-CoV-2 Immunity Persists for Up to 11 Months Following Infection

Valeria De Giorgi et al.

Summary: This study conducted a longitudinal analysis of COVID-19 convalescent plasma donors over an 11-month period, finding that most individuals maintained detectable levels of anti-SARS-CoV-2 IgG and neutralizing titers up to 11 months after symptom recovery. However, some donors experienced a decline in neutralization levels to undetectable titers over time.

JOURNAL OF INFECTIOUS DISEASES (2021)

Add to Collection

Article Immunology

Distinct antibody responses to SARS-CoV-2 in children and adults across the COVID-19 clinical spectrum

Stuart P. Weisberg et al.

Summary: This study found distinct antibody responses in children and adults after SARS-CoV-2 infection. Adult COVID-19 cohorts showed a broader range of antibody responses, while children predominantly generated antibodies specific for the S protein and had reduced neutralizing activity compared to adults.

NATURE IMMUNOLOGY (2021)

Add to Collection

Editorial Material Immunology

Serum IgA, IgM, and IgG responses in COVID-19

Huan Ma et al.

CELLULAR & MOLECULAR IMMUNOLOGY (2020)

Add to Collection

Article Immunology

Antibody Responses to SARS-CoV-2 in Patients With Novel Coronavirus Disease 2019

Juanjuan Zhao et al.

CLINICAL INFECTIOUS DISEASES (2020)

Add to Collection

Article Medicine, Research & Experimental

The role of interleukin-6 in monitoring severe case of coronavirus disease 2019

Tao Liu et al.

EMBO MOLECULAR MEDICINE (2020)

Add to Collection

Letter Respiratory System

Distinct features of SARS-CoV-2-specific IgA response in COVID-19 patients

Hai-qiong Yu et al.

EUROPEAN RESPIRATORY JOURNAL (2020)

Add to Collection

Editorial Material Multidisciplinary Sciences

Cytokine release syndrome in severe COVID-19

John B. Moore et al.

SCIENCE (2020)

Add to Collection

Article Medicine, General & Internal

SARS-CoV-2 and viral sepsis: observations and hypotheses

Hui Li et al.

LANCET (2020)

Add to Collection

Letter Medicine, General & Internal

Coagulopathy and Antiphospholipid Antibodies in Patients with Covid-19

Yan Zhang et al.

NEW ENGLAND JOURNAL OF MEDICINE (2020)

Add to Collection

Editorial Material Medicine, General & Internal

In Vitro Diagnostic Assays for COVID-19: Recent Advances and Emerging Trends

Sandeep Kumar Vashist

DIAGNOSTICS (2020)

Add to Collection

Review Pathology

Review of Current Advances in Serologic Testing for COVID-19

Andrea P. Espejo et al.

AMERICAN JOURNAL OF CLINICAL PATHOLOGY (2020)

Add to Collection

Article Pathology

SARS-CoV-2 Antibody Responses Do Not Predict COVID-19 Disease Severity

William S. Phipps et al.

AMERICAN JOURNAL OF CLINICAL PATHOLOGY (2020)

Add to Collection

Article Hematology

COVID-19 and coagulation: bleeding and thrombotic manifestations of SARS-CoV-2 infection

Hanny Al-Samkari et al.

BLOOD (2020)

Add to Collection

Article Hematology

Persisting SARS-CoV-2 viraemia after rituximab therapy: two cases with fatal outcome and a review of the literature

Phil-Robin Tepasse et al.

BRITISH JOURNAL OF HAEMATOLOGY (2020)

Add to Collection

Article Biochemistry & Molecular Biology

Structures of Human Antibodies Bound to SARS-CoV-2 Spike Reveal Common Epitopes and Recurrent Features of Antibodies

Christopher O. Barnes et al.

CELL (2020)

Add to Collection

Review Immunology

Lessons for COVID-19 Immunity from Other Coronavirus Infections

Alan Sariol et al.

IMMUNITY (2020)

Add to Collection

Editorial Material Immunology

Cytokine Storms: Understanding COVID-19

Nilam Mangalmurti et al.

IMMUNITY (2020)

Add to Collection

Article Immunology

Distinct Early Serological Signatures Track with SARS-CoV-2 Survival

Caroline Atyeo et al.

IMMUNITY (2020)

Add to Collection

Review Medicine, General & Internal

Pathophysiology, Transmission, Diagnosis, and Treatment of Coronavirus Disease 2019 (COVID-19) A Review

W. Joost Wiersinga et al.

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2020)

Add to Collection

Article Medicine, Research & Experimental

Severe immunosuppression and not a cytokine storm characterizes COVID-19 infections

Kenneth E. Remy et al.

JCI INSIGHT (2020)

Add to Collection

Article Pediatrics

COVID-19 in children and adolescents in Europe: a multinational, multicentre cohort study

Florian Goetzinger et al.

LANCET CHILD & ADOLESCENT HEALTH (2020)

Add to Collection

Article Biochemistry & Molecular Biology

Imbalance of Regulatory and Cytotoxic SARS-CoV-2-Reactive CD4+ T Cells in COVID-19

Benjamin J. Meckiff et al.

CELL (2020)

Add to Collection

Correction Biochemistry & Molecular Biology

Longitudinal Isolation of Potent Near-Germline SARS-CoV-2-Neutralizing Antibodies from COVID-19 Patients (vol 182, pg 843, 2020)

Christoph Kreer et al.

CELL (2020)

Add to Collection

Article Microbiology

Human B Cell Clonal Expansion and Convergent Antibody Responses to SARS-CoV-2

Sandra C. A. Nielsen et al.

CELL HOST & MICROBE (2020)

Add to Collection

Article Multidisciplinary Sciences

SARS-CoV-2-reactive T cells in healthy donors and patients with COVID-19

Julian Braun et al.

NATURE (2020)

Add to Collection

Article Multidisciplinary Sciences

Convergent antibody responses to SARS-CoV-2 in convalescent individuals

Davide F. Robbiani et al.

NATURE (2020)

Add to Collection

Review Cardiac & Cardiovascular Systems

COVID-19 and cardiovascular disease: from basic mechanisms to clinical perspectives

Masataka Nishiga et al.

NATURE REVIEWS CARDIOLOGY (2020)

Add to Collection

Article Immunology

Seroprevalence of anti-SARS-CoV-2 antibodies in COVID-19 patients and healthy volunteers up to 6 months post disease onset

Patricia Figueiredo-Campos et al.

EUROPEAN JOURNAL OF IMMUNOLOGY (2020)

Add to Collection

Article Multidisciplinary Sciences

Potent neutralizing antibodies from COVID-19 patients define multiple targets of vulnerability

Philip J. M. Brouwer et al.

SCIENCE (2020)

Add to Collection

Article Immunology

Orthogonal SARS-CoV-2 Serological Assays Enable Surveillance of Low-Prevalence Communities and Reveal Durable Humoral Immunity

Tyler J. Ripperger et al.

IMMUNITY (2020)

Add to Collection

Article Rheumatology

High rates of severe disease and death due to SARS-CoV-2 infection in rheumatic disease patients treated with rituximab: a descriptive study

Jesus Loarce-Martos et al.

RHEUMATOLOGY INTERNATIONAL (2020)

Add to Collection

Article Medicine, General & Internal

Occurrence and transmission potential of asymptomatic and presymptomatic SARS-CoV-2 infections: A living systematic review and meta-analysis

Diana Buitrago-Garcia et al.

PLOS MEDICINE (2020)

Add to Collection

Review Critical Care Medicine

Cytokine elevation in severe and critical COVID-19: a rapid systematic review, meta-analysis, and comparison with other inflammatory syndromes

Daniel E. Leisman et al.

LANCET RESPIRATORY MEDICINE (2020)

Add to Collection

Article Immunology

Persistence and decay of human antibody responses to the receptor binding domain of SARS-CoV-2 spike protein in COVID-19 patients

Anita S. Iyer et al.

SCIENCE IMMUNOLOGY (2020)

Add to Collection

Article Biochemistry & Molecular Biology

Compromised Humoral Functional Evolution Tracks with SARS-CoV-2 Mortality

Tomer Zohar et al.

CELL (2020)

Add to Collection

Article Biochemistry & Molecular Biology

Quick COVID-19 Healers Sustain Anti-SARS-CoV-2 Antibody Production

Yuezhou Chen et al.

CELL (2020)

Add to Collection

Review Medicine, General & Internal

Cytokine Storm

David C. Fajgenbaum et al.

NEW ENGLAND JOURNAL OF MEDICINE (2020)

Add to Collection

Article Multidisciplinary Sciences

Infection fatality rate of SARS-CoV2 in a super-spreading event in Germany

Hendrik Streeck et al.

NATURE COMMUNICATIONS (2020)

Add to Collection

Article Multidisciplinary Sciences

Preexisting and de novo humoral immunity to SARS-CoV-2 in humans

Kevin W. Ng et al.

SCIENCE (2020)

Add to Collection

Article Respiratory System

Persisting alterations of iron homeostasis in COVID-19 are associated with non-resolving lung pathologies and poor patients' performance: a prospective observational cohort study

Thomas Sonnweber et al.

RESPIRATORY RESEARCH (2020)

Add to Collection

Article Cell Biology

Cross-Sectional Evaluation of Humoral Responses against SARS-CoV-2 Spike

Jeremie Prevost et al.

CELL REPORTS MEDICINE (2020)

Add to Collection

Article Immunology

Pathological inflammation in patients with COVID-19: a key role for monocytes and macrophages

Miriam Merad et al.

NATURE REVIEWS IMMUNOLOGY (2020)

Add to Collection

Review Immunology

The trinity of COVID-19: immunity, inflammation and intervention

Matthew Zirui Tay et al.

NATURE REVIEWS IMMUNOLOGY (2020)

Add to Collection

Article Immunology

Persistence of serum and saliva antibody responses to SARS-CoV-2 spike antigens in COVID-19 patients

Baweleta Isho et al.

SCIENCE IMMUNOLOGY (2020)

Add to Collection

Review Immunology

Evolutionary conflicts between viruses and restriction factors shape immunity

Nisha K. Duggal et al.

NATURE REVIEWS IMMUNOLOGY (2012)

Add to Collection

Article Transplantation

Impact of iron treatment on immune effector function and cellular iron status of circulating monocytes in dialysis patients

Thomas Sonnweber et al.

NEPHROLOGY DIALYSIS TRANSPLANTATION (2011)

Add to Collection

Article Multidisciplinary Sciences

Aberrant innate immune response in lethal infection of macaques with the 1918 influenza virus

Darwyn Kobasa et al.

NATURE (2007)

Add to Collection

Article Multidisciplinary Sciences

Genomic analysis of increased host immune and cell death responses induced by 1918 influenza virus

John C. Kash et al.

NATURE (2006)

Add to Collection

© Peeref 2019-2024. All rights reserved.